Table 2. Univariate analysis of stage, LDH, IPI score, HP status and histologic subclassification in EFS and OS of gastric ‘pure' DLBCL patients.
| Variable | 5-Year EFS (%) | S.e. (%) | P-value | 5-Year OS (%) | S.e. (%) | P-value |
|---|---|---|---|---|---|---|
| Age (years old) | ||||||
| <60 | 61.8 | 7.5 | 0.048 | 68.9 | 7.2 | 0.032 |
| ⩾60 | 42.3 | 7 | 48.5 | 6.9 | ||
| Sex | ||||||
| Male | 48.8 | 7.6 | 0.452 | 60.5 | 7.5 | 0.767 |
| Female | 53 | 7.1 | 55 | 7 | ||
| Stage | ||||||
| I-IIE1 | 73.8 | 6.3 | <0.001 | 82.2 | 5.4 | <0.001 |
| IIE2/III/IV | 24.8 | 6.5 | 28.7 | 7 | ||
| ECOG | ||||||
| 0–1 | 58 | 5.5 | <0.001 | 65.5 | 5.3 | <0.001 |
| ⩾2 | 7.7 | 7.4 | 7.7 | 7.4 | ||
| LDH | ||||||
| Normal | 71.5 | 6.3 | <0.001 | 81.3 | 5.3 | <0.001 |
| High | 24.4 | 6.7 | 26.2 | 7 | ||
| IPI risk group | ||||||
| 0–1 | 72.3 | 6.4 | <0.001 | 82.7 | 5.2 | <0.001 |
| ⩾2 | 25.6 | 6.7 | 27 | 6.9 | ||
| HP status | ||||||
| Positive | 71.7 | 6.7 | <0.001 | 76.1 | 6.3 | <0.001 |
| Negative | 31.8 | 6.8 | 39.8 | 7.1 | ||
Abbreviation: DLBCL, diffuse large B-cell lymphoma; ECOG, Eastern Cooperative Oncology Group; EFS, event-free survival; EFS, event-free survival; LDH, lactate dehydrogenase; HP, H. pylori; IPI, International Prognostic Index; OS, overall survival; s.e., standard error.